Distinct Healthcare Holdings Limited will hold its annual general meeting on 24 June 2026 at 3:00 p.m. in the Executive Meeting Room, 4/F, Tower A, Wanrong Building, 1029 Nanhai Avenue, Nanshan District, Shenzhen, Guangdong Province, China.
Key resolutions submitted for shareholder approval are as follows:
• Financial Statements: Receive and adopt the audited consolidated financial statements of the company and its subsidiaries, together with the directors’ and auditors’ reports, for the year ended 31 December 2025.
• Board Re-elections: Re-elect Mr. Wang Zhiyuan as executive director; Mr. Zhang Xiangdong, Ms. Chen Xiaohong and Mr. Hao Rui as non-executive directors.
• Auditor: Re-appoint PricewaterhouseCoopers as external auditor and authorise the board to fix the remuneration.
• Share Repurchase Mandate: Authorise directors to repurchase up to 10% of the company’s issued shares, excluding any treasury shares, as at the date of the resolution.
• Issuance Mandate: Authorise directors to issue, allot or deal with additional shares and/or sell or transfer treasury shares up to 20% of the issued share capital, with an extension equal to the amount of shares that may be repurchased under the repurchase mandate.
• Directors’ Remuneration: Empower the board to set directors’ remuneration.
• Constitutional Update: Approve amendments to the existing Ninth Amended and Restated Memorandum and Articles of Association and adopt the Tenth Amended and Restated version.
Shareholders intending to vote by proxy must submit completed forms to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 3:00 p.m. on 22 June 2026.
Each ordinary share carries one vote. Joint holders’ voting will follow seniority as recorded in the share register. Attendance requires presentation of valid identification documents.
Comments